Understanding Urogenital Schistosomiasis-Related Bladder Cancer: An Update

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2018 Aug 31

PMID 30159314

Citations 36

Authors

Kenji Ishida

Michael H Hsieh

Affiliations

Soon will be listed here.

Abstract

Infection with leads to urogenital schistosomiasis, which has been correlated with the occurrence of bladder cancer. However, mechanisms responsible for this association have not yet been clearly identified. In this short review, we provide an update, highlighting the most recent studies on schistosome-associated bladder cancer, including those that focus on identifying changes in host biology during infection, as well as studies for the identification of potentially pro-carcinogenic parasite molecules, and we offer a discussion on some possible mechanisms driving schistosomal bladder cancer.

Citing Articles

Bispecific antibodies as powerful immunotherapeutic agents for urological cancers: Recent innovations based on preclinical and clinical evidence.

Hushmandi K, Einollahi B, Lee E, Sakaizawa R, Glaviano A, Reiter R Int J Biol Sci. 2025; 21(4):1410-1435.

PMID: 39990653 PMC: 11844292. DOI: 10.7150/ijbs.96155.

Microbiome in urologic neoplasms: focusing on tumor immunity.

Zou J, Xu B, Gao H, Luo P, Chen T, Duan H Front Immunol. 2024; 15:1507355.

PMID: 39703512 PMC: 11655508. DOI: 10.3389/fimmu.2024.1507355.

Herpes simplex virus type 2 in sub-Saharan Africa and the potential impact of helminth immune modulation.

Pillay R, Naidoo P, Mkhize-Kwitshana Z Front Cell Infect Microbiol. 2024; 14():1471411.

PMID: 39698320 PMC: 11652539. DOI: 10.3389/fcimb.2024.1471411.

O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.

Vasquez Martinez I, Perez-Campos E, Perez-Campos Mayoral L, Cruz Luis H, Pina Canseco M, Zenteno E Int J Mol Sci. 2024; 25(18).

PMID: 39337387 PMC: 11432004. DOI: 10.3390/ijms25189896.

Effects of Schistosoma haematobium infection and treatment on the systemic and mucosal immune phenotype, gene expression and microbiome: A systematic review.

Mertelsmann A, Bowers S, Wright D, Maganga J, Mazigo H, Ndhlovu L PLoS Negl Trop Dis. 2024; 18(9):e0012456.

PMID: 39250522 PMC: 11412685. DOI: 10.1371/journal.pntd.0012456.

References

Khaled H . Schistosomiasis and cancer in egypt: review. J Adv Res. 2015; 4(5):461-6. PMC: 4293882. DOI: 10.1016/j.jare.2013.06.007. View

Abdulamir A, Hafidh R, Kadhim H, Abubakar F . Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors. J Exp Clin Cancer Res. 2009; 28:27. PMC: 2650688. DOI: 10.1186/1756-9966-28-27. View

Mostafa M, Sheweita S, OConnor P . Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 1999; 12(1):97-111. PMC: 88908. DOI: 10.1128/CMR.12.1.97. View

Santos J, Fernandes E, Ferreira J, Lima L, Tavares A, Peixoto A . P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection. PLoS Negl Trop Dis. 2014; 8(12):e3329. PMC: 4263606. DOI: 10.1371/journal.pntd.0003329. View

Dematei A, Fernandes R, Soares R, Alves H, Richter J, Botelho M . Angiogenesis in Schistosoma haematobium-associated urinary bladder cancer. APMIS. 2017; 125(12):1056-1062. DOI: 10.1111/apm.12756. View

Brindley P, Costa J, Sripa B . Why does infection with some helminths cause cancer?. Trends Cancer. 2015; 1(3):174-182. PMC: 4657143. DOI: 10.1016/j.trecan.2015.08.011. View

Barsoum R . Urinary schistosomiasis: review. J Adv Res. 2015; 4(5):453-9. PMC: 4293885. DOI: 10.1016/j.jare.2012.08.004. View

Chala B, Choi M, Moon K, Kim H, Kwak C, Hong S . Development of Urinary Bladder Pre-Neoplasia by Eggs and Chemical Carcinogen in Mice. Korean J Parasitol. 2017; 55(1):21-29. PMC: 5365267. DOI: 10.3347/kjp.2017.55.1.21. View

Fu C, Apelo C, Torres B, Thai K, Hsieh M . Mouse bladder wall injection. J Vis Exp. 2011; (53):e2523. PMC: 3196188. DOI: 10.3791/2523. View

10.

Bernardo C, Cunha M, Santos J, Costa J, Brindley P, Lopes C . Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics. Tumour Biol. 2016; 37(8):11279-87. DOI: 10.1007/s13277-016-4997-y. View

11.

Nesi G, Nobili S, Cai T, Caini S, Santi R . Chronic inflammation in urothelial bladder cancer. Virchows Arch. 2015; 467(6):623-633. DOI: 10.1007/s00428-015-1820-x. View

12.

Botelho M, Oliveira P, Gomes J, Gartner F, Lopes C, Correia da Costa J . Tumourigenic effect of Schistosoma haematobium total antigen in mammalian cells. Int J Exp Pathol. 2009; 90(4):448-53. PMC: 2741155. DOI: 10.1111/j.1365-2613.2009.00650.x. View

13.

Greenman C, Stephens P, Smith R, Dalgliesh G, Hunter C, Bignell G . Patterns of somatic mutation in human cancer genomes. Nature. 2007; 446(7132):153-8. PMC: 2712719. DOI: 10.1038/nature05610. View

14.

Botelho M, Vale N, Gouveia M, Rinaldi G, Santos J, Santos L . Tumour-like phenotypes in urothelial cells after exposure to antigens from eggs of Schistosoma haematobium: an oestrogen-DNA adducts mediated pathway?. Int J Parasitol. 2012; 43(1):17-26. DOI: 10.1016/j.ijpara.2012.10.023. View

15.

Zhong X, Isharwal S, Naples J, Shiff C, Veltri R, Shao C . Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection. PLoS One. 2013; 8(3):e59089. PMC: 3601097. DOI: 10.1371/journal.pone.0059089. View

16.

Jourdan P, Roald B, Poggensee G, Gundersen S, Kjetland E . Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection. PLoS Negl Trop Dis. 2011; 5(6):e1170. PMC: 3110160. DOI: 10.1371/journal.pntd.0001170. View

17.

Machicado C, Marcos L . Carcinogenesis associated with parasites other than Schistosoma, Opisthorchis and Clonorchis: A systematic review. Int J Cancer. 2016; 138(12):2915-21. DOI: 10.1002/ijc.30028. View

18.

El-Aal A, Emran A, Al-Antably A, El Saftawy E, Bayoumy I, Hassan N . Immunohistochemical pattern of T lymphocytes population within bilharzial-associated bladder neoplasm microenvironment. Int J Immunopathol Pharmacol. 2015; 28(2):209-17. DOI: 10.1177/0394632015584733. View

19.

Shaker O, Hammam O, El Leithy T, El Ganzoury H, Wishahi M, Mikhailidis D . Molecular markers and bladder carcinoma: Schistosomal and non-schistosomal. Clin Biochem. 2010; 44(2-3):237-44. DOI: 10.1016/j.clinbiochem.2010.09.028. View

20.

Salem S, Mitchell R, El-Alim El-Dorey A, Smith J, Barocas D . Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt. BJU Int. 2011; 107(2):206-11. DOI: 10.1111/j.1464-410X.2010.09622.x. View